Medifast (MED) Long-Term Deferred Tax (2017 - 2025)

Medifast (MED) has 9 years of Long-Term Deferred Tax data on file, last reported at $12.1 million in Q3 2025.

• For the quarter ending Q3 2025, Long-Term Deferred Tax rose 202.55% year-over-year to $12.1 million; the trailing twelve-month figure through Sep 2025 stood at $12.1 million (up 202.55% YoY), and the FY2024 full-year result was $11.5 million, up 178.36% from the prior year.
• Long-Term Deferred Tax for Q3 2025 stood at $12.1 million, up from $11.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $12.1 million in Q3 2025 and bottomed at $692000.0 in Q1 2021.
• The 5-year median for Long-Term Deferred Tax is $4.4 million (2021), against an average of $5.8 million.
• The widest annual swing landed in 2021, when Long-Term Deferred Tax slumped 66.59%; it then jumped 788.73% in 2022.
• A 5-year view of Long-Term Deferred Tax shows it stood at $4.4 million in 2021, then climbed by 20.98% to $5.3 million in 2022, then declined by 22.73% to $4.1 million in 2023, then soared by 178.36% to $11.5 million in 2024, then advanced by 5.65% to $12.1 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $12.1 million (Q3 2025), $11.5 million (Q2 2025), and $11.4 million (Q1 2025), per Business Quant data.

Peer Comparison